Journal Article

Discovery of widespread type I and type V CRISPR-Cas inhibitors

Sousa, Alexander A., Joung, J. Keith, Kleinstiver, Benjamin P., Zhang, Jenny Y., Walton, Russell T., Marino, Nicole D., Borges, Adair L., Bondy-Denomy, Joseph, Leon, Lina M., Berry, Joel D., Rauch, Benjamin J.

2018

Overview

Bacteria and their phages continually coevolve in a molecular arms race. For example, phages use anti-CRISPR proteins to inhibit the bacterial type I and II CRISPR systems (see the Perspective by Koonin and Makarova). Watters et al. and Marino et al. used bioinformatic and experimental approaches to identify inhibitors of type V CRISPR-Cas12a. Cas12a has been successfully engineered for gene editing and nucleic acid detection. Some of the anti-Cas12a proteins identified in these studies had broad-spectrum inhibitory effects on Cas12a orthologs and could block Cas12a-mediated genome editing in human cells. Science , this issue p. 236 , p. 240 ; see also p. 156 CRISPR-Cas12a inhibitors that block gene editing in human cells are identified. Bacterial CRISPR-Cas systems protect their host from bacteriophages and other mobile genetic elements. Mobile elements, in turn, encode various anti-CRISPR (Acr) proteins to inhibit the immune function of CRISPR-Cas. To date, Acr proteins have been discovered for type I (subtypes I-D, I-E, and I-F) and type II (II-A and II-C) but not other CRISPR systems. Here, we report the discovery of 12 acr genes, including inhibitors of type V-A and I-C CRISPR systems. AcrVA1 inhibits a broad spectrum of Cas12a (Cpf1) orthologs—including MbCas12a, Mb3Cas12a, AsCas12a, and LbCas12a—when assayed in human cells. The acr genes reported here provide useful biotechnological tools and mark the discovery of acr loci in many bacteria and phages.

• Publisher: The American Association for the Advancement of Science
• Subject: Bacteria / Bacterial Proteins - antagonists & inhibitors / Bacterial Proteins - chemistry / Bacterial Proteins - genetics / Bacterial Proteins - metabolism / Biotechnology / Cell Line / Computational Biology - methods / CRISPR / CRISPR-Cas Systems / Endonucleases - antagonists & inhibitors / Gene Editing / Genes / Genetic modification / Genome editing / Genomes / Humans / Immune response / Inhibitors / Moraxella - genetics / Nucleic acids / Phages / Proteins / Pseudomonas - genetics